Ingalls & Snyder LLC’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,056
| Closed | -$44K | – | 417 |
|
|
2023
Q1 | $44K | Hold |
11,056
| – | – | ﹤0.01% | 402 |
|
|
2022
Q4 | $50K | Hold |
11,056
| – | – | ﹤0.01% | 407 |
|
|
2022
Q3 | $83K | Hold |
11,056
| – | – | ﹤0.01% | 391 |
|
|
2022
Q2 | $88K | Hold |
11,056
| – | – | ﹤0.01% | 402 |
|
|
2022
Q1 | $90K | Hold |
11,056
| – | – | ﹤0.01% | 421 |
|
|
2021
Q4 | $92K | Hold |
11,056
| – | – | ﹤0.01% | 430 |
|
|
2021
Q3 | $113K | Hold |
11,056
| – | – | 0.01% | 423 |
|
|
2021
Q2 | $114K | Hold |
11,056
| – | – | 0.01% | 426 |
|
|
2021
Q1 | $125K | Sell |
11,056
-6,000
| -35% | -$67.8K | 0.01% | 408 |
|
|
2020
Q4 | $184K | Hold |
17,056
| – | – | 0.01% | 393 |
|
|
2020
Q3 | $158K | Hold |
17,056
| – | – | 0.01% | 338 |
|
|
2020
Q2 | $163K | Sell |
17,056
-115,769
| -87% | -$1.11M | 0.01% | 367 |
|
|
2020
Q1 | $983K | Hold |
132,825
| – | – | 0.07% | 195 |
|
|
2019
Q4 | $1.11M | Hold |
132,825
| – | – | 0.06% | 186 |
|
|
2019
Q3 | $750K | Sell |
132,825
-13,221
| -9% | -$74.7K | 0.04% | 239 |
|
|
2019
Q2 | $1.14M | Sell |
146,046
-12,602
| -8% | -$98.7K | 0.06% | 205 |
|
|
2019
Q1 | $1.55M | Hold |
158,648
| – | – | 0.07% | 178 |
|
|
2018
Q4 | $1.24M | Hold |
158,648
| – | – | 0.07% | 186 |
|
|
2018
Q3 | $2.77M | Buy |
+158,648
| New | +$2.77M | 0.12% | 139 |
|